Lauren Santye, Assistant Editor

A general lack of knowledge for symptoms of cancer linked to regions where cancer survival is worse.

Six-week direct-acting antiviral treatment regimen with Sovaldi and ribavirin produced sub-optimal results in newly infected hepatitis C patients.

Top news of the day from across the health care landscape.

Crizotinib-pre-treated patients with non-small cell lung cancer experienced superior survival rates compared with chemotherapy.

ElastPQ technique can better detect liver fibrosis in patients with hepatitis C.

A new grant will fund a 5-year study on how mobile technology can assist minority patients with diabetes treatment adherence.

A health and exercise program may improve quality-of-life in patients recovering from bowel cancer.

Top news of the day from across the health care landscape.

Stool transplantation in patients who have an infection of the bowel with recurrent C. difficile shows promise.

Researchers unveil the molecular workings of MS drug Tecfidera using new technology.

Top news of the day from across the health care landscape.

Mark Tesell, PharmD, BCPS, clinical consultant pharmacist for UMass Medical School Clinical Pharmacy Services, discusses potential solutions for access to cholesterol lowering drugs to improve.

The loss of interleukin-33 allows tumors to hide from the immune system.

The rise in indoor temperatures worsened respiratory symptom scores and increased the use of recuse inhalers, a new study found.

Researchers have uncovered the mechanisms of resistance to Yervoy in patients with skin cancer.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how specialty pharmacies may need to alter current strategies with increasing attention on high drug costs.

Early intervention beneficial for pediatric eczema or atopic dermatitis in infants.

Study quantifies global body composition changes in patients with hepatitis C.

Natural killer cells ‘trained’ to more effectively attack cancer cells in patients with AML.

Top news of the day from across the health care landscape.

With no current treatments for patients with aggressive MS, new study findings provide hope.

The combined use of radiation therapy and a neutrophil stimulant can increase anti-tumor immunity.

Laquinimod provides hope for inhibiting aggressive multiple sclerosis.

New insights into a gene with anti-cancer activity may grow options for cancer treatment.

New findings could lead to antibiotic therapies for the late stages of a common bladder infection.

Study findings contribute to the development of personalized treatment approaches for young children with eczema.

A new report updates medical community on primary sclerosing cholangitis.

New study may have found a way to prevent the loss of physical strength in type 1 diabetes patients.

Rehydrating freeze-dried cellular components produces useful proteins.

Top news of the day from across the health care landscape.